The contract research organization Quintiles and Biogen Idec have entered into a five-year strategic clinical development agreement. The multiyear collaboration is designed to leverage the expertise and experience from both organizations to optimize Biogen Idec's clinical development processes.

Under the agreement, a dedicated team from Quintiles will work with Biogen Idec on the design, planning, and execution of Biogen Idec's Phase II-IV studies and select Phase I studies. In addition, Biogen Idec will leverage Quintiles' technology and systems across its portfolio. The Biogen Idec and Quintiles collaboration is already underway. New projects are being initiated through the collaboration, and several of Biogen Idec's ongoing studies are currently transitioning to Quintiles.

Source: Biogen Idec